Investors Should Buy This Stock on Any Dip in January (and Beyond)
Its discount should narrow in 2015 as the company continues to deliver solid revenue and earnings growth…
Read MoreAuthor: Bret Jensen, Biotech Gems
Two Speculative Stocks in 2015’s Hottest Sector
Posted by Bret Jensen, Biotech Gems | Jan 15, 2015
Both have market caps under $250 million and are worthy of consideration in a well-diversified biotech and biopharma portfolio…
Read MoreThese Two Speculative Stocks Look Attractive Right Now
Posted by Bret Jensen, Biotech Gems | Jan 7, 2015
They offer big potential to both save lives and earn profits…
Read MoreThese Two High Risk, High Reward Stocks Are Attractive Right Now
Posted by Bret Jensen, Biotech Gems | Dec 30, 2014
If everything falls right, they could power significantly higher in the upcoming year…
Read MoreThese Two Speculative Stocks Could Produce Major Returns
Posted by Bret Jensen, Biotech Gems | Dec 24, 2014
They’re cash-rich, small cap biotechs offering attractive risk/reward profiles right now…
Read More